30 results
6-K
EX-99.1
VALN
Valneva SE
5 Dec 23
Current report (foreign)
8:50am
infection and gestational age.
Fainting can occur with administration of IXCHIQ®. Procedures should be in place to avoid injury from fainting.
IXCHIQ
6-K
EX-99.1
VALN
Valneva SE
13 Nov 23
Current report (foreign)
6:10am
. Procedures should be in place to avoid injury from fainting.
IXCHIQ® may not protect all individuals who receive the vaccine.
Adverse Reactions
The most
6-K
EX-99.2
VALN
Valneva SE
21 Sep 23
Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates
10:52am
to dangerous and costly accidents that may result in accidental contamination or injury to people or the environment. Further, the business is subject
6-K
EX-99.2
djj7720dpij 9dog
11 Aug 22
Valneva Reports H1 2022 Results and Provides Corporate Updates
5:47pm
20-F
v1dcwevu
24 Mar 22
Annual report (foreign)
12:32pm
20-F
EX-10.6
vqant3e3xtmgmv
24 Mar 22
Annual report (foreign)
12:32pm
424B4
02e gy0il3wvaf
1 Nov 21
Prospectus supplement with pricing info
4:06pm
F-1
k17lr16m
26 Oct 21
Registration statement (foreign)
5:04pm
DRS
7ct9yk1ox7q6 k19
20 Oct 21
Draft registration statement
12:00am
6-K
EX-99.2
iwfnli buhbu1b
10 Aug 21
Valneva Reports H1 2021 Financial Results and Provides Business Update
5:25pm
424B4
n109dq0 m8
7 May 21
Prospectus supplement with pricing info
4:06pm
F-1/A
l9sx9zsnfh3k6w9kx4
5 May 21
Registration statement (foreign) (amended)
6:07am
F-1/A
oaf9i de8pb
29 Apr 21
Registration statement (foreign) (amended)
6:08am
F-1/A
oskp8fdc2ss 6err
21 Apr 21
Registration statement (foreign) (amended)
5:06pm
F-1
EX-10.5
x2ud57f17wzn
9 Apr 21
Registration statement (foreign)
4:06pm
F-1
c5vhu8n49i0xu
9 Apr 21
Registration statement (foreign)
4:06pm